INKT — MiNK Therapeutics, Inc.

INKTMiNK Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · minktherapeutics.com

12.71USD+4.27%Mkt Cap: 62.15M USDP/E: —Last update: 2026-06-01

MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, manufacture, and commercialization of allogeneic, off-the-shelf, and invariant natural killer T (iNKT) cell ther…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap62.15M USD

Enterprise Value51.25M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-12.49M USD

Revenue/Share—

Last Price12.71 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees15

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-4.27

PEG—

EV/EBITDA-4.00

EV/Revenue—

P/S—

P/B-4.78

EPS (TTM)-2.80

EPS (Forward)-2.85

52W Range

6.8009% of range76.00

52W High76.00 USD

52W Low6.800 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE87.82%

ROA-87.75%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-5.93M USD

CapEx (TTM)—

FCF Margin—

FCF Yield-8.28%

Net Debt-9.53M USD

Net Debt/EBITDA0.74

Balance Sheet

Debt/Equity-0.36

Current Ratio1.38

Quick Ratio1.31

Book Value/Sh-2.5530 USD

Cash/Share1.912 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateJan 28, 2025

Analyst Consensus

Rating1.0 (Strong Buy)

Target (Mean)39.00 USD

Target Range35.00 USD – 43.00 USD

# Analysts2

Ownership

Shares Out.4.98M

Float1.96M

Insiders60.47%

Institutions2.53%

Short Interest

Short Ratio2.9d

Short % Float5.05%

Short % Out.2.47%

Shares Short122.96K

Short (prev mo.)96.49K

Technical

SMA 5011.07 (+14.9%)

SMA 20012.40 (+2.5%)

Beta—

S&P 52W Chg27.94%

Avg Vol (30d)38.48K

Avg Vol (10d)51.87K

Technical Indicators

RSI (14)59.3

MACD-0.0147

MACD Signal-0.1409

MACD Hist.+0.1262

BB Upper12.17 USD

BB Middle11.04 USD

BB Lower9.906 USD

BB Width20.48%

ATR (14)0.9129 USD

Vol Ratio (20d)1.65x